The 6 most recent market catalysts affecting $CARL, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Oct 12, 2026
Corporate Catalyst
Bullish
Impact 55
BTIG Maintains Buy on Carlsmed, Raises Price Target to $24
BTIG analyst Ryan Zimmerman maintained a 'Buy' rating on Carlsmed and modestly increased the price target from $23 to $24. This action signals ongoing analyst conviction in the com…
Sep 28, 2026
Corporate Catalyst
Neutral
Impact 55
BTIG Reiterates Buy on Carlsmed, Maintains $23 Price Target
BTIG analyst Ryan Zimmerman reiterated a 'Buy' rating and maintained a $23 price target for Carlsmed (CARL). This action signals continued confidence from a prominent investment ba…
Sep 28, 2026
Corporate Catalyst
Bearish
Impact 55
Carlsmed Affirms FY2026 Sales Guidance of $74.000M-$78.000M vs $74.830M Est
Carlsmed (CARL) filed an 8-K to affirm its fiscal year 2026 sales guidance, which remains in the range of $74.000 million to $78.000 million. This is a routine disclosure, as the c…
Sep 28, 2026
Corporate Catalyst
Neutral
Impact 75
Carlsmed Appoints Richard Heppenstall CFO, Succeeding Leo Greenstein; Co. Reiterates FY26 Revenue Range Of $74M - $78M
Carlsmed announced the appointment of Richard Heppenstall as its new Chief Financial Officer, effective immediately, succeeding Leo Greenstein. This is a significant executive chan…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Securities Maintains Buy on Carlsmed, Raises Price Target to $20
Truist Securities analyst Richard Newitter maintained a 'Buy' rating on Carlsmed (CARL) and raised the price target from $18 to $20. This action signals a positive outlook from a r…
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 75
Carlsmed Raises FY2026 Sales Guidance from $72.000M-$77.000M to $74.000M-$78.000M vs $74.830M Est
Carlsmed (CARL) has filed an 8-K to announce an upward revision to its FY2026 sales guidance. The company's new outlook is $74.000 million-$78.000 million, up from the previous $72…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.